Literature DB >> 14679397

Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders.

Annick Vogels1, Jenneke Van Den Ende, Kathelijne Keymolen, Geert Mortier, Koen Devriendt, E Legius, J P Fryns.   

Abstract

The identification of all people with a diagnosis of Prader-Willi syndrome (PWS) confirmed by DNA methylation analysis living in Flanders was attempted through contact with the four genetic centres and the PWS Association. The birth incidence for the period 1993-2001 was 1:26 676, the minimum prevalence at 31 December 2001 was 1:76 574. A decreasing number of cases with age was found, which can be explained by a number of missing cases in the older population, a higher neonatal mortality in the past and an increasing mortality with age. Childhood death is usually sudden and associated with respiratory infection and high temperature, while the cause of death in adults is considered to be circulatory or respiratory in origin.

Entities:  

Mesh:

Year:  2004        PMID: 14679397     DOI: 10.1038/sj.ejhg.5201135

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  38 in total

Review 1.  Death during GH therapy in children with Prader-Willi syndrome: description of two new cases.

Authors:  G Grugni; C Livieri; A Corrias; A Sartorio; A Crinò
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

2.  Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark.

Authors:  E Hedgeman; S P Ulrichsen; S Carter; N C Kreher; K P Malobisky; M M Braun; J Fryzek; M S Olsen
Journal:  Int J Obes (Lond)       Date:  2017-06-21       Impact factor: 5.095

3.  Contributing factors of mortality in Prader-Willi syndrome.

Authors:  Jennifer Proffitt; Kathryn Osann; Barbara McManus; Virginia E Kimonis; Janalee Heinemann; Merlin G Butler; David A Stevenson; June-Anne Gold
Journal:  Am J Med Genet A       Date:  2018-12-19       Impact factor: 2.802

4.  Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.

Authors:  T Cadoudal; M Buléon; C Sengenès; G Diene; F Desneulin; C Molinas; S Eddiry; F Conte-Auriol; D Daviaud; P G P Martin; A Bouloumié; J-P Salles; M Tauber; P Valet
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

5.  Neural correlates of self-injurious behavior in Prader-Willi syndrome.

Authors:  Megan Klabunde; Manish Saggar; Kristin M Hustyi; Jennifer L Hammond; Allan L Reiss; Scott S Hall
Journal:  Hum Brain Mapp       Date:  2015-07-14       Impact factor: 5.038

6.  Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.

Authors:  Dong-Kyu Jin
Journal:  Korean J Pediatr       Date:  2012-07-17

7.  Social/economic costs and health-related quality of life in patients with rare diseases in Europe.

Authors:  Julio López-Bastida; Juan Oliva-Moreno; Renata Linertová; Pedro Serrano-Aguilar
Journal:  Eur J Health Econ       Date:  2016-03-29

8.  Sudden cardiac death in a child affected by Prader-Willi syndrome.

Authors:  Cristoforo Pomara; Stefano D'Errico; Irene Riezzo; Gian Pio de Cillis; Vittorio Fineschi
Journal:  Int J Legal Med       Date:  2005-03-05       Impact factor: 2.686

9.  Scoliosis in patients with Prader Willi Syndrome - comparisons of conservative and surgical treatment.

Authors:  Hans-Rudolf Weiss; Deborah Goodall
Journal:  Scoliosis       Date:  2009-05-06

10.  Nutritient intake of young children with Prader-Willi syndrome.

Authors:  Marianne Lindmark; Kerstin Trygg; Kaja Giltvedt; Svein O Kolset
Journal:  Food Nutr Res       Date:  2010-03-17       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.